Ahmet Guzel

Dr. Ahmet Guzel

Department of Urology, Aydın State Hospital, Aydın, TURKEY
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2012 in Andrologia
Verified
Journal Article
Closed access
PDF file
TOT. Oksay
T. Oksay
MNM. Naziroğlu
M. Naziroğlu
SDS. Doğan
S. Doğan
AGAhmet Guzel
Ahmet Guzel
NGN. Gümral
N. Gümral
PKP. A. Koşar
P. A. Koşar
Wireless devices have become part of everyday life and mostly located near reproductive organs while they are in use. The present study was designed to determine the possible protective effects of melatonin on oxidative stress-dependent testis injury induced by 2.45-GHz electromagnetic radiation (EMR). Thirty-two rats were equally divided into four different groups, namely cage control (A1), sham control (A2), 2.45-GHz EMR (B) and 2.45-GHz EMR+melatonin (C). Group B and C were exposed to 2.45-GHz EMR during 60 min day(-1) for 30 days. Lipid peroxidation levels were higher in Group B than in Group A1 and A2. Melatonin treatment prevented the increase in the lipid peroxidation induced by EMR. Also reduced glutathione (GSH) and glutathione peroxidase (GSH-Px) levels in Group D were higher than that of exposure group. Vitamin A and E concentrations decreased in exposure group, and melatonin prevented the decrease in vitamin E levels. In conclusion, wireless (2.45 GHz) EMR caused oxidative damage in testis by increasing the levels of lipid peroxidation and decreasing in vitamin A and E levels. Melatonin supplementation prevented oxidative damage induced by EMR and also supported the antioxidant redox system in the testis.

3 June 2021 in Medicina
Verified
Journal Article
Open access
PDF file
AGAhmet Guzel
Ahmet Guzel
SYSedat Yunusoglu
Sedat Yunusoglu
MCMustafa CALAPOGLU
Mustafa CALAPOGLU
ICIbrahim Aydın Candan
Ibrahim Aydın Candan
IOIbrahim Onaran
Ibrahim Onaran
TOTaylan Oksay
Taylan Oksay
Background and Objectives: The most common kidney stones are calcium stones and calcium oxalate (CaOx) stones are the most common type of calcium stones. Hyperoxaluria is an essential risk factor for the formation of these stones. Quercetin is a polyphenol with antioxidant, anti-inflammatory, and many other physiological effects. The aim of this study was to investigate the protective effect of quercetin in hyperoxaluria-induced nephrolithiasis. Materials and Methods: Male Wistar-Albino rats weighing 250–300 g (n = 24) were randomized into three groups: Control (n = 8), ethylene glycol (EG) (n = 8), and EG + quercetin (n = 8). One percent EG-water solution was given to all rats except for the control group as drinking water for five weeks. Quercetin-water solution was given to the EG + quercetin group by oral gavage at a dose of 10 mg/kg/day. Malondialdehyde (MDA), catalase (CAT), urea, calcium, and oxalate levels were analyzed in blood and urine samples. Histopathological assessments and immunohistochemical analyses for oxidative stress and inflammation indicators p38 mitogen-activated protein kinase (p38-MAPK) and nuclear factor kappa B (NF-kB) were performed on renal tissues. Results: The MDA levels were significantly lower in the quercetin-treated group than in the EG-treated group (p = 0.001). Although CAT levels were higher in the quercetin-treated group than the EG-administered group, they were not significantly different between these groups. The expression of p38 MAPK was significantly less in the quercetin-treated group than the EG group (p < 0.004). There was no statistically significant difference between the quercetin and EG groups in terms of NF-kB expression. Conclusions: We conclude that hyperoxaluria activated the signaling pathways, which facilitate the oxidative processes leading to oxalate stone formation in the kidneys. Our findings indicated that quercetin reduced damage due to hyperoxaluria. These results imply that quercetin can be considered a therapeutic agent for decreasing oxalate stone formation, especially in patients with recurrent stones due to hyperoxaluria.


22 September 2013 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
AÖAlper Özorak
Alper Özorak
MHMustafa Burak Hoşcan
Mustafa Burak Hoşcan
TOTaylan Oksay
Taylan Oksay
AGAhmet Guzel
Ahmet Guzel
AKAlim Koşar
Alim Koşar

1 January 2015 in International Journal of Surgery Case Reports
Verified
Journal Article
Open access
MPMustafa Pehlivan
Mustafa Pehlivan
PÖPelin Özün Özbay
Pelin Özün Özbay
MTMuzaffer Temür
Muzaffer Temür
ÖYÖzgür Yılmaz
Özgür Yılmaz
ZGZekeriya Gümüş
Zekeriya Gümüş
AGAhmet Guzel
Ahmet Guzel
Introduction: Epidermoid cysts can occur in a variety of locations including face, trunk, neck, extremities and scalp. Up to now, those vulvar epidermal cysts reported in the literature were localized on the labia majora and the clitoris. This is the first case of epidermal cyst reported on the labia minora. Presentation of case: A 47-year-old, multiparous woman presented with a history of a palpable vulvar mass, without pain but causing difficulty in walking. The large mass was 6 cm in diameter and located in the left labium minus. The labial mass was surgically removed. The final pathologic diagnosis was a vulvar epidermoid cyst. The patient was discharged from hospital without any complications. Discussion: Total surgical excision of the mass is more appropriate for definitive histopathological diagnosis and for the prevention of future development of complications. MRI is very important in the localization of the mass and relationship with other tissues regarding treatment planning of larger vulvar masses. Conclusion: Epidermal cysts should be considered in the differential diagnosis of a vulvar mass. Highlights:

26 April 2015 in International Urology and Nephrology
Verified
Journal Article
Closed access
PDF file
OEOsman Ergün
Osman Ergün
AGAhmet Guzel
Ahmet Guzel
AAAbdullah Armağan
Abdullah Armağan
AKAlim Koşar
Alim Koşar
AEAyşe Gül Ergün
Ayşe Gül Ergün